Cencora (COR) competitors & alternatives
Health Care · NYSE
Cencora (COR)'s top competitors and alternatives — its most similar public companies — include McKesson Corporation (MCK), Cardinal Health (CAH), OPTION CARE HEALTH INC (OPCH), ONCOLOGY INSTITUTE INC (TOI), Henry Schein (HSIC), Centene Corporation (CNC), CVS Health (CVS), AMNEAL PHARMACEUTICALS INC CLASS A (AMRX), Avantor (AVTR), FENNEC PHARMACEUTICALS INC (FENC), GUARDIAN PHARMACY SERVICES INC CLA (GRDN) and Labcorp (LH). These are Cencora's closest public-company peers by sub-industry, sector and business themes and is informational only — not financial advice.
Top COR competitors & alternatives
-
McKesson CorporationMCKHealth Care
McKesson is a healthcare services giant that orchestrates the entire pharmaceutical and medical supply chain—from drug distribution and specialty oncology care…
$814.04 (as of 2026-07-22) · market cap $96.6B
-
Cardinal HealthCAHHealth Care
Cardinal Health is a healthcare services and logistics company that distributes pharmaceuticals, medical supplies, and healthcare IT solutions to pharmacies,…
$220.54 (as of 2026-07-22) · market cap $53.0B
-
OPTION CARE HEALTH INCOPCHHealth Care
Option Care Health is the nation’s largest independent provider of home and alternate site infusion services, delivering cost-effective, patient-centered care…
$21.15 (as of 2026-07-22) · market cap $3.3B
-
ONCOLOGY INSTITUTE INCTOIHealth Care
The Oncology Institute is a value-based oncology care provider that manages outpatient cancer treatment through a national network of clinics and integrated…
$5.29 (as of 2026-07-22) · market cap $529M
-
Henry ScheinHSICHealth Care
A global, one-stop-shop distributor of medical and dental supplies, specialized equipment, and practice management software for office-based health care…
$84.81 (as of 2026-07-22) · market cap $9.6B
-
Centene CorporationCNCHealth Care
The nation's largest managed care insurer for underserved populations, connecting 27.6 million Medicaid, Medicare, and Marketplace members with affordable…
$65.89 (as of 2026-07-22) · market cap $33.0B
-
CVS HealthCVSHealth Care
CVS Health is an integrated health care giant combining extensive retail pharmacy networks, pharmacy benefits management, and comprehensive health insurance…
$108.08 (as of 2026-07-22) · market cap $140.4B
-
AMNEAL PHARMACEUTICALS INC CLASS AAMRXHealth Care
Amneal Pharmaceuticals is a diversified biopharma company providing a broad range of essential, affordable generic and specialty medicines, alongside…
$17.75 (as of 2026-07-22) · market cap $5.7B
-
AvantorAVTRHealth Care
Global provider of mission-critical laboratory consumables, specialty chemicals, and biopharmaceutical manufacturing solutions serving life sciences,…
$10.95 (as of 2026-07-22) · market cap $7.5B
-
FENNEC PHARMACEUTICALS INCFENCHealth Care
Commercial-stage biopharma company bringing PEDMARK, the first and only approved drug to prevent cisplatin-induced ototoxicity in pediatric cancer patients, to…
$10.32 (as of 2026-07-22) · market cap $359M
-
GUARDIAN PHARMACY SERVICES INC CLAGRDNHealth Care
Guardian is a specialized pharmacy services provider delivering high-touch clinical and dispensing solutions to long-term care facilities, particularly…
$39.77 (as of 2026-07-22) · market cap $2.6B
-
LabcorpLHHealth Care
A global diagnostics and drug development laboratory leader that performs 750+ million clinical tests annually and supports 85% of new FDA-approved drugs…
$281.46 (as of 2026-07-22) · market cap $23.1B
Not quite? Describe exactly what you want →
Peers are Cencora's closest public companies by shared sub-industry, sector and business themes. See the full profile: Cencora (COR).
Last updated 2026-07-22.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.